Serum C-reactive protein is linked to cerebral microstructural integrity and cognitive function

Objective: C-reactive protein is a marker of inflammation and vascular disease. It also seems to be associated with an increased risk of dementia. To better understand potential underlying mechanisms, we assessed microstructural brain integrity and cognitive performance relative to serum levels of high-sensitivity C-reactive protein (hs-CRP). Methods: We cross-sectionally examined 447 community-dwelling and stroke-free individuals from the Systematic Evaluation and Alteration of Risk Factors for Cognitive Health (SEARCH) Health Study (mean age 63 years, 248 female). High-field MRI was performed in 321 of these subjects. Imaging measures included fluid-attenuated inversion recovery sequences for assessment of white matter hyperintensities, automated quantification of brain parenchyma volumes, and diffusion tensor imaging for calculation of global and regional white matter integrity, quantified by fractional anisotropy (FA). Psychometric analyses covered verbal memory, word fluency, and executive functions. Results: Higher levels of hs-CRP were associated with worse performance in executive function after adjustment for age, gender, education, and cardiovascular risk factors in multiple regression analysis (β = −0.095, p = 0.02). Moreover, higher hs-CRP was related to reduced global fractional anisotropy (β = −0.237, p < 0.001), as well as regional FA scores of the frontal lobes (β = −0.246, p < 0.001), the corona radiata (β = −0.222, p < 0.001), and the corpus callosum (β = −0.141, p = 0.016), in particular the genu (β = −0.174, p = 0.004). We did not observe a significant association of hs-CRP with measures of white matter hyperintensities or brain atrophy. Conclusion: These data suggest that low-grade inflammation as assessed by high-sensitivity C-reactive protein is associated with cerebral microstructural disintegration that predominantly affects frontal pathways and corresponding executive function.

[1]  J. Liao,et al.  Genetically elevated C-reactive protein and ischemic vascular disease , 2009, Current atherosclerosis reports.

[2]  S. Knecht,et al.  Caloric restriction improves memory in elderly humans , 2009, Proceedings of the National Academy of Sciences.

[3]  R. Morris,et al.  Imaging age‐related cognitive decline: A comparison of diffusion tensor and magnetization transfer MRI , 2009, Journal of magnetic resonance imaging : JMRI.

[4]  L. Fried,et al.  Executive decline and dysfunction precedes declines in memory: the Women's Health and Aging Study II. , 2009, The journals of gerontology. Series A, Biological sciences and medical sciences.

[5]  W. M. van der Flier,et al.  Heterogeneity of White Matter Hyperintensities in Alzheimer's Disease: Post-Mortem Quantitative MRI and Neuropathology , 2008, Brain : a journal of neurology.

[6]  P. Libby,et al.  Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. , 2008, The New England journal of medicine.

[7]  Robert H. Paul,et al.  Elevated C‐Reactive Protein Is Related to Cognitive Decline in Older Adults with Cardiovascular Disease , 2008, Journal of the American Geriatrics Society.

[8]  Chris A Clark,et al.  Multimodal MRI in Cerebral Small Vessel Disease: Its Relationship With Cognition and Sensitivity to Change Over Time , 2008, Stroke.

[9]  Bruce M Psaty,et al.  Biomarkers of Inflammation and MRI-Defined Small Vessel Disease of the Brain: The Cardiovascular Health Study , 2008, Stroke.

[10]  E. Ringelstein,et al.  High-Normal Blood Pressure Is Associated With Poor Cognitive Performance , 2008, Hypertension.

[11]  Klaus Berger,et al.  CRP Gene Haplotypes, Serum CRP, and Cerebral Small-Vessel Disease: The Rotterdam Scan Study and the MEMO Study , 2007, Stroke.

[12]  Michael Deppe,et al.  Diffusion-Tensor Imaging at 3 T: Detection of White Matter Alterations in Neurological Patients on the Basis of Normal Values , 2007, Investigative radiology.

[13]  Y. Assaf,et al.  Diffusion Tensor Imaging (DTI)-based White Matter Mapping in Brain Research: A Review , 2007, Journal of Molecular Neuroscience.

[14]  A. Berghold,et al.  C-Reactive Protein, Carotid Atherosclerosis, and Cerebral Small-Vessel Disease: Results of the Austrian Stroke Prevention Study , 2006, Stroke.

[15]  D. Tate,et al.  C-reactive protein, but not homocysteine, is related to cognitive dysfunction in older adults with cardiovascular disease , 2006, Journal of Clinical Neuroscience.

[16]  R. Paul,et al.  Evaluating elements of executive functioning as predictors of instrumental activities of daily living (IADLs). , 2006, Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists.

[17]  N. Cook,et al.  High-Sensitivity C-Reactive Protein and Cognitive Function in Older Women , 2006, Epidemiology.

[18]  P. Box Cerebral small-vessel disease and decline in information processing speed, executive function and memory , 2006 .

[19]  R. Sacco,et al.  Interleukin-6 is associated with cognitive function: the Northern Manhattan Study. , 2006, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[20]  C. Bouchard,et al.  Effect of exercise training on plasma levels of C-reactive protein in healthy adults: the HERITAGE Family Study. , 2005, European heart journal.

[21]  Niels D Prins,et al.  Cerebral small-vessel disease and decline in information processing speed, executive function and memory. , 2005, Brain : a journal of neurology.

[22]  A Hofman,et al.  C-Reactive Protein and Cerebral Small-Vessel Disease: The Rotterdam Scan Study , 2005, Circulation.

[23]  R. Jung Neuropsychological Assessment, 4th ed. , 2005 .

[24]  S. Kritchevsky,et al.  Inflammatory markers and cardiovascular health in older adults. , 2005, Cardiovascular research.

[25]  J. Smit,et al.  Serum inflammatory proteins and cognitive decline in older persons , 2005, Neurology.

[26]  M. Hori,et al.  Relations of Serum High-Sensitivity C-Reactive Protein and Interleukin-6 Levels With Silent Brain Infarction , 2005, Stroke.

[27]  Sidney C. Smith,et al.  MARKERS OF INFLAMMATION AND CARDIOVASCULAR DISEASE: APPLICATION TO CLINICAL AND PUBLIC HEALTH PRACTICE: A STATEMENT FOR HEALTHCARE PROFESSIONALS FROM THE CENTERS FOR DISEASE CONTROL AND PREVENTION AND THE AMERICAN HEART ASSOCIATION , 2003 .

[28]  Hugh S Markus,et al.  Markers of endothelial dysfunction in lacunar infarction and ischaemic leukoaraiosis. , 2003, Brain : a journal of neurology.

[29]  Gary L Myers,et al.  Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. , 2003, Circulation.

[30]  Stephen M. Smith,et al.  Accurate, Robust, and Automated Longitudinal and Cross-Sectional Brain Change Analysis , 2002, NeuroImage.

[31]  R. Schmidt,et al.  Early inflammation and dementia: A 25‐year follow‐up of the Honolulu‐Asia aging study , 2002, Annals of neurology.

[32]  Ose,et al.  Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events* , 2002 .

[33]  Natalia S. Rost,et al.  Plasma Concentration of C-Reactive Protein and Risk of Ischemic Stroke and Transient Ischemic Attack: The Framingham Study , 2001, Stroke.

[34]  P. Ridker,et al.  Variability and classification accuracy of serial high-sensitivity C-reactive protein measurements in healthy adults. , 2001, Clinical chemistry.

[35]  James T. Willerson,et al.  Direct Proinflammatory Effect of C-Reactive Protein on Human Endothelial Cells , 2000, Circulation.

[36]  M. Visser,et al.  Elevated C-reactive protein levels in overweight and obese adults. , 1999, JAMA.

[37]  M. Horsfield,et al.  Optimal strategies for measuring diffusion in anisotropic systems by magnetic resonance imaging , 1999, Magnetic resonance in medicine.

[38]  Frederik Barkhof,et al.  White Matter Changes on CT and MRI: An Overview of Visual Rating Scales , 1998, European Neurology.

[39]  F Fazekas,et al.  White matter changes on CT and MRI: an overview of visual rating scales. European Task Force on Age-Related White Matter Changes. , 1998, European neurology.

[40]  P. Ridker,et al.  Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. , 1997, The New England journal of medicine.

[41]  W. Meier-Ruge,et al.  Age‐Related White Matter Atrophy in the Human Brain , 1992, Annals of the New York Academy of Sciences.

[42]  I. Das,et al.  Raised C-reactive protein levels in serum from smokers. , 1985, Clinica chimica acta; international journal of clinical chemistry.